NeuroPace, Inc. (NPCE) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NPCE Revenue Growth
Revenue Breakdown
NPCE's revenue distribution by segment and geography
By Geography
NPCE Revenue Analysis (2019–2025)
As of May 8, 2026, NeuroPace, Inc. (NPCE) generated trailing twelve-month (TTM) revenue of $100.0 million, reflecting exceptional growth of +23.9% year-over-year. The most recent quarter (Q4 2025) recorded $26.6 million in revenue, down 2.8% sequentially.
Looking at the longer-term picture, NPCE's 5-year compound annual growth rate (CAGR) stands at +19.4%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $100.0 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including LIVN (+12.4% YoY), ELMD (+15.5% YoY), and MDT (+6.9% YoY), NPCE has outperformed the peer group in terms of revenue growth. Compare NPCE vs LIVN →
NPCE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NPCECurrent | $100M | +23.9% | +19.4% | -16.3% | |
 LIVN | $1.4B | +12.4% | +8.2% | 14.4% | |
 ELMD | $64M | +15.5% | +14.5% | 15.1% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% |
NPCE Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $100.0M | +25.1% | $77.2M | 77.2% | $-16,338,000 | -16.3% |
| 2024 | $79.9M | +22.1% | $59.1M | 73.9% | $-21,671,000 | -27.1% |
| 2023 | $65.4M | +43.7% | $48.1M | 73.6% | $-27,174,000 | -41.5% |
| 2022 | $45.5M | +0.7% | $32.5M | 71.4% | $-40,794,000 | -89.6% |
| 2021 | $45.2M | +9.8% | $33.4M | 74.0% | $-23,737,000 | -52.5% |
| 2020 | $41.1M | +11.3% | $30.3M | 73.6% | $-13,051,000 | -31.7% |
| 2019 | $37.0M | - | $26.5M | 71.6% | $-22,031,000 | -59.6% |
See NPCE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NPCE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NPCE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNPCE — Frequently Asked Questions
Quick answers to the most common questions about buying NPCE stock.
Is NPCE's revenue growth accelerating or slowing?
NPCE revenue is accelerating at +23.9% year-over-year, exceeding the 5-year CAGR of +19.4%. TTM revenue reached $100M. Growth momentum has increased versus prior periods.
What is NPCE's long-term revenue growth rate?
NeuroPace, Inc.'s 5-year revenue CAGR of +19.4% reflects the sustained expansion pattern. Current YoY growth of +23.9% is above this long-term average.
How is NPCE's revenue distributed by segment?
NPCE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.